Tumor profiling

Search documents
Natera (NasdaqGS:NTRA) FY Conference Transcript
2025-09-23 15:30
Natera (NasdaqGS:NTRA) FY Conference September 23, 2025 10:30 AM ET Speaker0All right. Hey, everyone. Thanks for being here, small but hearty crowd. Appreciate having you here. I am E.Bernstein, not related to Bernstein, different spelling. But I cover U. S. Life science tools and diagnostics. And it's my pleasure to have Mike Brophy here with us today.Mike joined Natera in 2015. You served as VP of Corporate Development and Investor Relations and SVP of Finance and Investor Relations before, starting as CF ...
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
Prnewswireยท 2025-07-30 13:15
Early-access customer Weiyi Chen, PhD, HCLD (ABB), technical director, Molecular Diagnostics at siParadigm Diagnostic Informatics, noted the assay's distinct advantages. "We are very excited about the launch of TSO 500 v2. We found improved accuracy of data results with TSO 500 v2 compared to our current solution from a different vendor," said Chen. "The new workflow is fast and streamlined with HRD included. Turnaround time is very important to our lab so we can quickly access results. The solution will al ...